Ergomed plc provides clinical research, and drug development and safety and medical information services in the United Kingdom and internationally. The company offers clinical development, trial management, and pharmacovigilance services for pharmaceutical and generics companies, as well as small and mid-sized drug development companies. It focuses on various therapeutic areas, including oncology, neurology, and immunology, as well as the development of orphan drugs.
Read More…
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+44-1483-503205
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales£54.11 million
Profitability
Miscellaneous
Employees700
Next Earnings DateN/A
OptionableNot Optionable
Ergomed (LON:ERGO) Frequently Asked Questions
What is Ergomed's stock symbol?
Ergomed trades on the London Stock Exchange (LON) under the ticker symbol "ERGO."
How were Ergomed's earnings last quarter?
Ergomed PLC (LON:ERGO) released its quarterly earnings results on Monday, September, 18th. The company reported $1.20 EPS for the quarter. The company earned $22.91 million during the quarter. View Ergomed's Earnings History.
What price target have analysts set for ERGO?
1 brokers have issued 12-month price objectives for Ergomed's shares. Their forecasts range from GBX 267 to GBX 267. On average, they expect Ergomed's share price to reach GBX 267 in the next twelve months. This suggests that the stock has a possible downside of 10.1%. View Analyst Price Targets for Ergomed.
What is the consensus analysts' recommendation for Ergomed?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ergomed in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Ergomed.
Has Ergomed been receiving favorable news coverage?
Media headlines about ERGO stock have been trending positive on Thursday, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Ergomed earned a media sentiment score of 2.8 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for Ergomed.
Who are some of Ergomed's key competitors?
Some companies that are related to Ergomed include Oxford BioMedica (OXB), Kodiak Sciences (KOD), Neptune Wellness Solutions (NEPT), Starpharma (SPL), BELLUS Health (BLU), ProMetic Life Sciences (PLI), Biotest (BIO), Theratechnologies (TH), Senesco Technologies (ELOX), Emerald Health Therapeutics (EMH), Monash IVF Group (MVF), Rafael (RFL), Paradigm Biopharmaceuticals (PAR), Emblem (EMC) and 22nd Century Group (XXII).
What other stocks do shareholders of Ergomed own?
Who are Ergomed's key executives?
Ergomed's management team includes the folowing people:
- Dr. Miroslav Reljanovic, Founder & Exec. Chairman (Age 60)
- Dr. Jan Petracek, COO & Director (Age 43)
- Mr. Stuart Robert Jackson, CFO & Director (Age 59)
- Ms. Sanja Juric, Gen. Counsel & Company Sec.
- Dr. Michael Forstner, Head of Risk Management & Pharmacoepidemiology
How do I buy shares of Ergomed?
Shares of ERGO and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Ergomed's stock price today?
One share of ERGO stock can currently be purchased for approximately GBX 297.
How big of a company is Ergomed?
What is Ergomed's official website?
How can I contact Ergomed?
Ergomed's mailing address is 26-24 Frederick Sanger Road, GUILDFORD, GU2 7YD, United Kingdom. The company can be reached via phone at +44-1483-503205.
MarketBeat Community Rating for Ergomed (LON ERGO)
MarketBeat's community ratings are surveys of what our community members think about Ergomed and other stocks. Vote "Outperform" if you believe ERGO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ERGO will underperform the S&P 500 over the long term. You may vote once every thirty days.
